Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6804926> ?p ?o }
Showing triples 1 to 49 of
49
with 100 triples per page.
- Q6804926 subject Q6996306.
- Q6804926 subject Q6996388.
- Q6804926 subject Q6996516.
- Q6804926 subject Q6999003.
- Q6804926 subject Q7487449.
- Q6804926 abstract "MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) was a decision by the Supreme Court of the United States involving patent law. It arose from a lawsuit filed by MedImmune which challenged one of the Cabilly patents issued to Genentech. One of the central issues was whether a licensee retained the right to challenge a licensed patent, or whether this right was forfeited upon signing of the license agreement. The case related indirectly to past debate over whether the US should change to a first to file patent system - in 2011, President Obama signed the Leahy-Smith America Invents Act, which shifted the United States to a first to file patent system.The origin of the dispute was a lengthy interference proceeding between Genentech and Celltech which led to the issuance of a new patent in 2001, 18 years after the original filing. This effectively granted Genentech a patent term of 29 years. MedImmune was a licensee of the later Cabilly patent, but argued that the term had been improperly extended and that it need not continue to pay royalties past the original expiry date in March 2006. The case was decided in favor of MedImmune, and the United States Patent and Trademark Office (USPTO) declared the patent invalid. Genentech appealed the USPTO the ruling and the patent remained valid and enforceable until the appeal was concluded. Genentech prevailed during the reexamination of Cabilly II(2) by the USPTO (1). GlaxoSmithKline and Human Genome Sciences both are challenging the patent under antitrust law (1). This is based on the settlement between Genentech and Celltech and their dispute over the original Cabilly patent 4,816,567 and the Celltech's patent 4,816,397. Both of which issued on March 28, 1989 (2),(3). Cabilly II is patent 6331415(4) which issued December 18, 2001.".
- Q6804926 wikiPageExternalLink 2007DLTR0008.html.
- Q6804926 wikiPageExternalLink 3-2.html.
- Q6804926 wikiPageExternalLink 4816397.
- Q6804926 wikiPageExternalLink 4816567.
- Q6804926 wikiPageExternalLink 6331415.
- Q6804926 wikiPageExternalLink the-never-ending-battle-over-genentechs-cabilly-ii-patent.
- Q6804926 wikiPageExternalLink -biotech-patents-genentech-claims-rejected-on-patent-which-was-subject-of-recent-supreme-court-decision.html.
- Q6804926 wikiPageExternalLink -biotech-patents-genentech-hit-with-adverse-patent-ruling.html.
- Q6804926 wikiPageExternalLink Teskin11-03.pdf.
- Q6804926 wikiPageExternalLink busimlo183336_31896.shtml.
- Q6804926 wikiPageExternalLink uspto-issues-double-patenting-rejection-on-genentechs-29-year-patent.
- Q6804926 wikiPageWikiLink Q11142.
- Q6804926 wikiPageWikiLink Q11201.
- Q6804926 wikiPageWikiLink Q1335294.
- Q6804926 wikiPageWikiLink Q13847185.
- Q6804926 wikiPageWikiLink Q1459541.
- Q6804926 wikiPageWikiLink Q253623.
- Q6804926 wikiPageWikiLink Q3039740.
- Q6804926 wikiPageWikiLink Q3246000.
- Q6804926 wikiPageWikiLink Q4737048.
- Q6804926 wikiPageWikiLink Q5015393.
- Q6804926 wikiPageWikiLink Q5058338.
- Q6804926 wikiPageWikiLink Q5454262.
- Q6804926 wikiPageWikiLink Q6602066.
- Q6804926 wikiPageWikiLink Q6996306.
- Q6804926 wikiPageWikiLink Q6996388.
- Q6804926 wikiPageWikiLink Q6996516.
- Q6804926 wikiPageWikiLink Q6999003.
- Q6804926 wikiPageWikiLink Q7311531.
- Q6804926 wikiPageWikiLink Q7487449.
- Q6804926 wikiPageWikiLink Q899140.
- Q6804926 wikiPageWikiLink Q908639.
- Q6804926 fullname "MedImmune, Inc. v. Genentech, Inc.".
- Q6804926 type Case.
- Q6804926 type LegalCase.
- Q6804926 type SupremeCourtOfTheUnitedStatesCase.
- Q6804926 type UnitOfWork.
- Q6804926 type Situation.
- Q6804926 type Thing.
- Q6804926 type Q2334719.
- Q6804926 comment "MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007) was a decision by the Supreme Court of the United States involving patent law. It arose from a lawsuit filed by MedImmune which challenged one of the Cabilly patents issued to Genentech. One of the central issues was whether a licensee retained the right to challenge a licensed patent, or whether this right was forfeited upon signing of the license agreement.".
- Q6804926 label "MedImmune, Inc. v. Genentech, Inc.".
- Q6804926 name "MedImmune, Inc. v. Genentech, Inc.".